JP2023508852A5 - - Google Patents

Info

Publication number
JP2023508852A5
JP2023508852A5 JP2022536653A JP2022536653A JP2023508852A5 JP 2023508852 A5 JP2023508852 A5 JP 2023508852A5 JP 2022536653 A JP2022536653 A JP 2022536653A JP 2022536653 A JP2022536653 A JP 2022536653A JP 2023508852 A5 JP2023508852 A5 JP 2023508852A5
Authority
JP
Japan
Prior art keywords
cancer cells
tumor vaccine
personalized
personalized tumor
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022536653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/064412 external-priority patent/WO2021119376A1/en
Publication of JP2023508852A publication Critical patent/JP2023508852A/ja
Publication of JP2023508852A5 publication Critical patent/JP2023508852A5/ja
Pending legal-status Critical Current

Links

JP2022536653A 2019-12-11 2020-12-11 個別化腫瘍ワクチンおよびがん免疫療法のためのその使用 Pending JP2023508852A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962946934P 2019-12-11 2019-12-11
US62/946,934 2019-12-11
PCT/US2020/064412 WO2021119376A1 (en) 2019-12-11 2020-12-11 Personalized tumor vaccine and use thereof for cancer immunotherapy

Publications (2)

Publication Number Publication Date
JP2023508852A JP2023508852A (ja) 2023-03-06
JP2023508852A5 true JP2023508852A5 (https=) 2023-10-17

Family

ID=76330549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536653A Pending JP2023508852A (ja) 2019-12-11 2020-12-11 個別化腫瘍ワクチンおよびがん免疫療法のためのその使用

Country Status (7)

Country Link
US (1) US20230054318A1 (https=)
EP (1) EP4072580A4 (https=)
JP (1) JP2023508852A (https=)
KR (1) KR20220141280A (https=)
CN (1) CN114929265A (https=)
AU (1) AU2020403013A1 (https=)
WO (1) WO2021119376A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021186246A1 (en) * 2020-03-19 2021-09-23 Trizell Ltd. Temperature-responsive virus storage system
WO2022197599A1 (en) * 2021-03-18 2022-09-22 Ne1 Inc. Cancer vaccine and method of use thereof
CN115252782B (zh) * 2022-07-28 2023-05-19 重庆医科大学 一种携氧仿生分子探针及其制备方法和在hifu及免疫协同治疗癌症中的应用
EP4687901A1 (en) * 2023-03-29 2026-02-11 Biocanim A.s. A pharmaceutical combination for use in the treatment of cancer
CN117903980B (zh) * 2024-01-05 2024-10-18 四川大学 一种海氏肠球菌及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009046739A1 (en) * 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating prostate cancer (pca)
US9370558B2 (en) * 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
GB0907989D0 (en) * 2009-05-08 2009-06-24 Hybrid Systems Ltd Multivalent adjuvant display
EP2714076A1 (en) * 2011-05-26 2014-04-09 GlaxoSmithKline Biologicals S.A. Inactivated dengue virus vaccine

Similar Documents

Publication Publication Date Title
JP2023508852A5 (https=)
JP5185813B2 (ja) 癌免疫治療のための組成物および方法
KR101755526B1 (ko) 알파-갈락토실 세라미드 유사체, 및 면역요법제, 아주반트, 및 항바이러스제, 항박테리아제, 및 항암제로서의 그의 용도
JP6781204B2 (ja) 高い炭水化物抗原密度を有するワクチン及び新規サポニンアジュバント
TW200911274A (en) Alpha-galatosyl ceramide analogs and their use as immunotherapies
WO2017118695A1 (en) Therapeutic anticancer neoepitope vaccine
Liu et al. The adjuvant of α-galactosylceramide presented by gold nanoparticles enhances antitumor immune responses of MUC1 antigen-based tumor vaccines
Jin et al. Preparation and evaluation of the adjuvant effect of curdlan sulfate in improving the efficacy of dendritic cell-based vaccine for antitumor immunotherapy
TWI861015B (zh) 包含抗原肽-佐劑核苷酸結合物之免疫誘導劑及包含其之醫藥組成物
WO2007084661B1 (en) Therapy-enhancing glucan
KR101566847B1 (ko) 항원에 대한 면역 반응 증강을 위한 글리코실세라마이드의 용도
ES2730649T3 (es) Glicolípidos modificados y procedimientos de preparación y uso de los mismos
Lee et al. Biodegradable cationic polycarbonates as vaccine adjuvants
CN101500580A (zh) 具有增强的Th-1模式的C-糖脂
EP1973571A1 (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
JP2023073529A (ja) 複合体
JP7296644B2 (ja) 免疫応答を強化するための複合物の調製方法
WO2017212197A1 (fr) Diéthers d'archaea lipides synthétiques
JP2018537490A (ja) スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物
Rosales-Mendoza et al. Nanogels-Based Mucosal Vaccines
CN117244053B (zh) 具有常春藤皂苷元-O-Ara结构的化合物的佐剂用途
Martínez-López et al. TB or Not TB: The Parallel Lives of BCG
TW202600165A (zh) 佐劑組合物、包含該佐劑組合物的藥物組合物以及預防或治療病毒感染、細菌感染、原蟲感染或癌症引起的疾病的方法
JP2005247861A (ja) 免疫増強特性を有するムチンペプチド
RU2021124842A (ru) Препарат вакцины против рака